Monitoring the US for unlawful claims for dietary supplements to treat COVID-19 continues taking up much of the Food and Drug Administration’s time. Not enough, though, to keep the agency from warning firms in the consumer health products space that are crossing other regulatory lines.
The latest warning letters published by the FDA include not only two more about claims for supplements to prevent or...







